Back to results
US 2015/0031682 A1Published application
Anti-malarial agents
AssigneesMmv Medicines for Malaria Venture, University of Cape Town
InventorsYassir Younis, Kelly Chibale, Michael John Witty, David Waterson
Life of this patent
Estimating the term…
Abstract
The present invention is related to a use of aminopyrazine derivatives in the manufacture of a medicament for preventing or treating malaria. Specifically, the present invention is related to aminopyrazine derivatives useful for the preparation of a pharmaceutical formulation for the inhibition of malaria parasite proliferation.
Claims24
1-27. (canceled)
An aminopyrazine according to Formula (I),
- wherein X is CR1 or N;
- Y is selected from CF3, —C(O)—NR3R4;
- O—R6;
- SO2—R6;
- R1 is selected from H and halogen;
- R2 is selected from SO2—R5 and —C(O)—R10;
- R3 and R4 are independently selected from H and optionally substituted C1-C6 alkyl;
- R5 is selected from —NR7R8 and R9;
- R6 is optionally substituted C1-C6 alkyl;
- R7 and R8 are independently selected from H and optionally substituted C1-C6 alkyl;
- R9 is optionally substituted C1-C6 alkyl or optionally substituted C3-C8 alkyl;
- R10 is —NR11R12;
- R11 and R12 are independently selected from H and optionally substituted C1-C6 alkyl or NR11R12 form together an optionally substituted heterocycloalkyl;
- as well as pharmaceutically acceptable salts, complexes, hydrates, solvates, or polymorphs, tautomers, geometrical isomers, optically active forms and pharmaceutically active derivative thereof.
11 more elements
An intermediate of formula (xix) wherein the intermediate is selected from the following group:
- tert-butyl 4-(4-(5-amino-6-(4-(trifluoromethyl)phenyl)pyrazin-2-yl)benzoyl)piperazine-1-carboxylate and tert-butyl 4-(4-(5-amino-6-(6-(trifluoromethyl) pyridin-3-yl)pyrazin-2-yl)benzoyl) piperazine-1-carboxylate.
Dependencies are inferred from the claim text.